Tadalafil /Cialis Powder CAS 171596-29-5 For Male Erectile Dysfunction
Detalles Rápidos:
nombre del producto:Tadalafil
Sinónimos:(6r,12ar)-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione
CASO:171596-29-5
MF: C22H19N3O4
MW:389.4
EINECS: 200-835-2
Propiedades químicas:White to off-white cyrstalline solid
Ensayo:99%
MP: 298-300° C
Usos:It is a kind of PDE-5 inhibitors which can be used for the treatment of male erectile dysfunction. It is also the second generation of phosphodiesterase type 5 inhibitors used to treat male erectile dysfunction.
Tadalafil COA:
| Elementos |
Enterprise |
Result |
| Descripción |
Off-white or white crystalline powder |
Polvo cristalino blanco |
| Identificación |
IRHPLC |
Conform to standard |
| Pérdida por secado |
≤0,5% |
0.1% |
| Residuos en ignición |
≤0.1% |
0.03% |
| Metales pesados |
≤0.002% |
<0.002% |
| Related substances |
Individual impurity≤0.1% |
0.03% |
| Total impurities≤0.3% |
≤0.3% |
| Ensayo |
97.5~102.5% |
99.82% |
Aplicaciones:
Although sildenafil (viagra), vardenafil (Levitra), and tadalafil (cialis) all work by inhibiting PDE5, tadalafil’s pharmacologic distinction is its longer half-life (17.50 horas) – compared to sildenafil (4.0–5.0 hours) and vardenafil (4.0–5.0 hours) – resulting in longer duration of action, and so partly responsible for “The Weekend Pill” sobriquet. además, the longer half-life is the basis for current investigation of tadalafil’s daily therapeutic use in relieving pulmonary arterial hypertension. Sildenafil is approved in several world regions as a thrice-daily therapy for pulmonary arterial hypertension.
Gerente de ventas